Takeda Director Higashi Emiko Files Initial Ownership Statement
TAKEDA PHARMACEUTICAL CO LTD
Subscribe to track TAK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Takeda Director Higashi Emiko Files Initial Ownership Statement
Company: TAKEDA PHARMACEUTICAL CO LTD (TAK) Form: 3 | Filed: 2026-03-18 Significance: Low
Insider: Higashi Emiko Title: Director | Relationship: Director
Transaction: • Type: Initial Statement of Beneficial Ownership • Shares: 0 (Initial Disclosure of Holdings) • Price: $N/A • Value: $N/A • Owned After: 25,400 (Direct)
Key Insight: Director Emiko Higashi discloses initial beneficial ownership of 7,600 ADS and 17,800 Ordinary Shares (including RSUs) upon joining the board.
Market Context: Routine compliance filing establishing baseline ownership for a new director; no open market transaction occurred.
Comprehensive Analysis
SEC Filing Analysis: TAKEDA PHARMACEUTICAL CO LTD (TAK)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Director Emiko Higashi files initial statement of beneficial ownership (Form 3) disclosing ~25,400 shares/ADS.
- Market Impact: Neutral - This is a routine compliance filing indicating no new market activity.
Company Information
| Field | Value |
|---|---|
| Company | TAKEDA PHARMACEUTICAL CO LTD |
| Ticker Symbol | TAK |
| CIK | 0001395064 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Higashi Emiko |
| CIK | 0001318086 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 3 |
| Transaction Date | 2026-03-18 (Report Date) |
| Transaction Code | None (Initial Statement) |
| Security Type | American Depositary Shares & Ordinary Shares |
| Shares Involved | 0 (Holdings Disclosure) |
| Price Per Share | N/A |
| Total Value | N/A |
| Shares Owned After | 25,400 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 (Initial Filing) |
| % of Market Cap | 0% |
| Shares Transacted | 0 |
| % of Shares Outstanding | 0% |
| Post-Transaction Ownership | 25,400 shares (0.0016% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $8,979.44 billion, the disclosed holdings are immaterial to the broader capital structure.
- Ownership Concentration: The insider holds a negligible percentage (<0.01%) of the 1.59 billion shares outstanding.
- Dilution Impact: None; this filing discloses existing equity awards and holdings, not new issuances.
- Transaction Significance: Purely administrative; establishes the baseline for future Section 16 reporting.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Form 3 filings are procedural requirements for new directors and do not represent active buying or selling pressure.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Holdings Detail: Disclosure includes 7,600 ADS and 17,800 Ordinary Shares (which include 12,800 unvested RSUs).
- Derivatives: Insider also holds Tax Obligation Awards equivalent to ~6,956 shares vesting between 2026 and 2028.
- Address: Filer address listed c/o KLA Corporation, suggesting cross-board experience.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.